ApoA-I from people with Type 1 diabetes showed significant Arg and Lys depletion, but not Trp loss compared to controls, consistent with the known kinetics of modification of side-chain residues by these agents [33]. Here, APOA1 is linked to type 1 diabetes mellitus.